Last reviewed · How we verify
NCT03771768: BD
Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease
NA trial testing Diode laser 980nm&100 mWatt in Autoimmune in 38 participants. Status unknown.
25 May 2019
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 38 |
| Start date | 25 May 2019 |
| Primary completion | 25 May 2019 |
| Estimated completion | 25 May 2019 |
Drugs / interventions tested
- Diode laser 980nm&100 mWatt
- Triamcinolone Acetonide — full drug profile →
Conditions studied
- Autoimmune — all drugs for Autoimmune →
- Behcet Syndrome — all drugs for Behcet Syndrome →
Sponsor
Cairo University
Who can join
Adults 18 to 60, any sex, with Autoimmune or Behcet Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Laser therapy is increasingly showing promising results in dental field including oral ulcers.This trial will assess the usefulness of Diode Laser compared to corticosteroid on oral ulcers of patients diagnosed with Behcet's disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluation of diode laser versus topical corticosteroid in management of Behcet's disease-associated oral ulcers: a randomized clinical trial.
Nagieb CS, Harhash TA, Fayed HL, Ali S. · · 2022 · cited 6× · PMID 34212234 · DOI 10.1007/s00784-021-04047-8
Verify or expand the search:
- PubMed search for NCT03771768
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Autoimmune
Currently open trials in the same condition.
- NCT07144462 — A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patient · EARLY_PHASE1 · recruiting
- NCT05697159 — 7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis · recruiting
- NCT05866861 — A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus · Phase 1 · active not recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03771768 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 9 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03771768.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing